Gyre Therapeutics (GYRE) Amortizatization of Intangibles (2010 - 2015)
Gyre Therapeutics (GYRE) posted quarterly Amortizatization of Intangibles of $63000.0 for Q2 2015, down 72.12% year-over-year from $226000.0 in Q2 2014, and down 35.05% quarter-over-quarter from $97000.0 in Q1 2015.
Gyre Therapeutics (GYRE) Amortizatization of Intangibles (2010 - 2015) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Amortizatization of Intangibles for 6 consecutive years, with $63000.0 the latest figure, recorded in Q2 2015.
- In Q2 2015, Amortizatization of Intangibles fell 72.12% year-over-year to $63000.0; the TTM figure through Jun 2015 stood at $484000.0 (down 41.62% YoY), while the FY2014 annual figure was $775000.0, down 14.65% from the prior year.
- Amortizatization of Intangibles fell to $63000.0 in Q2 2015 per GYRE's latest filing, from $97000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $335000.0 in Q3 2011 and bottomed at $63000.0 in Q2 2015.
- Historically, Amortizatization of Intangibles has averaged $205055.6 across 5 years, with a median of $225500.0 in 2013.
- Annual changes were most pronounced in 2011 — Amortizatization of Intangibles surged 125.0% — and 2015, when it slumped 72.12%.
- Gyre Therapeutics' Amortizatization of Intangibles stood at $270000.0 in 2011, then fell by 23.33% to $207000.0 in 2012, then advanced by 10.14% to $228000.0 in 2013, then slumped by 37.72% to $142000.0 in 2014, then tumbled by 55.63% to $63000.0 in 2015.
- Business Quant data shows GYRE's Amortizatization of Intangibles at $63000.0 in Q2 2015, $97000.0 in Q1 2015, and $142000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.33 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 678,000.00 |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 63,000.00 |
| Jun 30, 2015 | 63,000.00 |
| Mar 31, 2015 | 97,000.00 |
| Mar 31, 2015 | 97,000.00 |
| Dec 31, 2014 | 142,000.00 |
| Dec 31, 2014 | 142,000.00 |
| Sep 30, 2014 | 182,000.00 |
| Sep 30, 2014 | 182,000.00 |
| Jun 30, 2014 | 226,000.00 |
| Jun 30, 2014 | 226,000.00 |
| Mar 31, 2014 | 225,000.00 |
| Mar 31, 2014 | 225,000.00 |
| Dec 31, 2013 | 228,000.00 |
| Dec 31, 2013 | 228,000.00 |
| Sep 30, 2013 | 150,000.00 |
| Sep 30, 2013 | 150,000.00 |
| Jun 30, 2013 | 304,000.00 |
| Jun 30, 2013 | 304,000.00 |
| Mar 31, 2013 | 226,000.00 |
| Mar 31, 2013 | 226,000.00 |